| Literature DB >> 20485434 |
Peter W Gething1, David L Smith, Anand P Patil, Andrew J Tatem, Robert W Snow, Simon I Hay.
Abstract
The current and potential future impact of climate change on malaria is of major public health interest. The proposed effects of rising global temperatures on the future spread and intensification of the disease, and on existing malaria morbidity and mortality rates, substantively influence global health policy. The contemporary spatial limits of Plasmodium falciparum malaria and its endemicity within this range, when compared with comparable historical maps, offer unique insights into the changing global epidemiology of malaria over the last century. It has long been known that the range of malaria has contracted through a century of economic development and disease control. Here, for the first time, we quantify this contraction and the global decreases in malaria endemicity since approximately 1900. We compare the magnitude of these changes to the size of effects on malaria endemicity proposed under future climate scenarios and associated with widely used public health interventions. Our findings have two key and often ignored implications with respect to climate change and malaria. First, widespread claims that rising mean temperatures have already led to increases in worldwide malaria morbidity and mortality are largely at odds with observed decreasing global trends in both its endemicity and geographic extent. Second, the proposed future effects of rising temperatures on endemicity are at least one order of magnitude smaller than changes observed since about 1900 and up to two orders of magnitude smaller than those that can be achieved by the effective scale-up of key control measures. Predictions of an intensification of malaria in a warmer world, based on extrapolated empirical relationships or biological mechanisms, must be set against a context of a century of warming that has seen marked global declines in the disease and a substantial weakening of the global correlation between malaria endemicity and climate.Entities:
Mesh:
Year: 2010 PMID: 20485434 PMCID: PMC2885436 DOI: 10.1038/nature09098
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962
Figure 1Changing global malaria endemicity since 1900
a, Pre-intervention endemicity (c. 1900) as defined by Lysenko16. b, Contemporary endemicity for 2007 based on a recent global project to define the limits and intensity of current P. falciparum transmission8. c, Change in endemicity class between c.1900 and 2007. Negative values denote a reduction in endemicity, positive values an increase.
Comparison of magnitude of changes (effect size) in the basic reproductive number in relevant observational or predictive studies
| effect size | Study | |
|---|---|---|
|
| ||
| Proportion of 1900 endemic world by area | Current study | |
| 13% | ÷ ≤1 | |
| 12% | ÷ 1 - 10 | |
| 18% | ÷ 10 - 100 | |
| 57% | ÷ >100 | |
|
| ||
| Spatially aggregated mean change by ~2050 |
| |
|
| × 1.27 (1.16 - 1.74) | |
|
| × 1.23 (1.15 - 1.39) | |
| Range of local changes by ~2050 | × 0 - 2 |
|
| Range of local changes by ~2080 | × 0 - 2 |
|
| Range of local changes by ~2050 | × 0 - 3 |
|
| ACTs (compared to failing pre-ACT treatment) | ÷ 1.1 - 1.8 |
|
| ITNs (at 40-60% effective coverage) | ÷ 5 - 15 |
|
| ITNs + LCI (both at “moderate” coverage levels) | ÷ 15 - 25 |
|
| Western Kenya | ÷ 7.2 |
|
| São Tomé and Principe | ÷ 5.1 |
|
| Bioko Island | ÷ 2.9 |
|
| Southern Mozambique | ÷ 78.8 |
|
| Zanzibar | ÷ 1.6 |
|
ACT = Artemisinin-based Combination Therapy; EIR = Entomological Inoculation Rate; IPTp =Iintermittent Preventive Treatment in Pregnancy; ITN = Insecticide Treated Bednet; LCI = Larval Control Intervention
Percentages do not sum to 100 due to rounding.
Consists of 11% of land area with no evidence of change, and 2% with evidence of increased transmission.
The available results relate to the combined Africa, South-East Asia, Central and South America regions. Given are central modelled values and uncertainty intervals associated with plausible ranges of input biological parameters.
Results obtained using the MIASMA linked climate-biological model, under three future climate scenarios, and only the largest predicted changes are shown here.
In the original study, results were not presented for areas with very low baseline potential to avoid using infinitesimal values as denominators in the comparison.
Results apply to both P. falciparum and P. vivax.
Range of predicted changes included a ‘ >2 ’ category but no further details provided.
Study reported predicted changes in parasite rate from five real-world baseline endemicity settings under failing treatment regimes based on pre-ACT monotherapies (Table 4 in reference). We converted transitions in parasite rate into transitions in R0 to estimate effect size.
Study modelled effect size as a continuous function of ITN effective coverage. Values presented based on Figure 1 in reference.
Study reported effect sizes in terms of EIR, which were interpreted directly as R0 effect sizes.
Results from a control trial.
Integrated malaria control effort involving mass intervention coverage complemented with health system strengthening. Reported decline relates to period 2005-2007.
Study reported reduction in community parasite rate from 30.5% to 2.1% following expanded control efforts. We converted this into transitions in R0 to estimate effect size.
Integrated malaria control effort involving mass IRS administration, improved case management with ACT and strengthened health system surveillance and diagnostics. Reported decline relates to period 2004-2005.
Study reported reduction in community parasite rate from 46% to 31% following expanded control efforts. We converted this into transitions in R0 to estimate effect size.
Integrated malaria control effort involving IRS administration, improved case management with ACT and strengthened health systems. Reported decline relates to period 1999-2005.
Study reported reduction in community parasite rate from 65% to 4% in study zone with longest running intervention coverage (Zone 1, values taken from Table 1 of reference). We converted this into transitions in R0 to estimate effect size.
Integrated malaria control effort involving scale up of long-lasting ITNs from 10% to 90% coverage of children, switch from chloroquine to ACT as first and second line therapeutic and strengthened surveillance and health systems. Reported decline relates to period 2003-2005.
Study reported reduction in parasite rate in children 0-5yrs from 9% to 0.3% and in children 6-14yrs from 12.9% to 1.7% following expanded control efforts. We converted this into transitions in R0 to estimate effect size.